Johnson & Johnson (JNJ – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Lee ...

Analysts discuss Johnson & Johnson's outlook, highlighting MedTech challenges, litigation risks, pipeline opportunities, and mixed performance across segments.

President Donald Trump's boost to AI demand hopes is outweighing fresh tariff threats on China and the EU, as earnings season ...

Companies are posting robust results so far this earnings season, but the bar is high for stock gains to continue.

Wall Street's indexes rose on Wednesday, with the benchmark S&P 500 hitting an intraday record high as investors cheered streaming video provider Netflix's quarterly report and President Donald ...

Loss of breadth: Check. A handful of technology giants-what UBS calls the 'Magnificent Six,' which excludes Tesla -are driving the market, while smaller stocks lag. The average 12-month forward ...

The forced social media break was short-lived, however, as TikTok access in the U.S. was reinstated a mere 12 hours later.

During an interview Wednesday night with Fox News’s Sean Hannity, Trump claimed that his thinking about FEMA had recently shifted, not the least bit because it sometimes helps people in liberal states ...

On Wednesday, the House of Representatives passed the Senate’s version of the Laken Riley Act, which allows for the ...

Stifel analyst Rick Wise lowered the firm’s price target on Johnson & Johnson to $155 from $170 and keeps a Hold rating on the shares.

We recently published a list of Jim Cramer Discusses TikTok Ban, President Trump & These 6 Stocks. In this article, we are ...